(RTTNews) - Mersana Therapeutics (MRSN) announced the FDA recently granted an additional Fast Track designation to XMT-1660. The new Fast Track designation is for the treatment of advanced or ...
Mersana Therapeutics (MRSN) announced the U.S. FDA recently granted an additional Fast Track designation to XMT-1660. The company also announced that the World Health Organization has approved ...
Mersana Therapeutics, Inc. announced that the FDA has granted an additional Fast Track designation for its drug XMT-1660, also known as emiltatug ledadotin (Emi-Le), aimed at treating advanced or ...
The company also announced that the World Health Organization has approved emiltatug ledadotin (abbreviated as Emi-Le) as XMT-1660’s international nonproprietary name (INN). The new Fast Track ...
The company also announced that the World Health Organization has approved emiltatug ledadotin (abbreviated as Emi-Le) as XMT-1660’s international nonproprietary name (INN). The new Fast Track ...
Observed at 05:00, Monday 13 January BBC Weather in association with MeteoGroup, external All times are Japan Standard Time (Asia/Tokyo, GMT+9) unless otherwise stated.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback